BioMed Central | Articles which cite: Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed.

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed.
Sawada-Hirai R, Jiang I, Wang F, Sun SM, Nedellec R, Ruther P, Alvarez A, Millis D, Morrow PR, Kang AS
J Immune Based Ther Vaccines 2004 May 12, 2:5
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis. Pittman PR, Leitman SF, Oro JG, Norris SL, Marano NM, Ranadive MV, Sink BS, McKee KT Clin Diagn Lab Immunol 2005 Jun, 12:713-21 [PubMed Central] [PubMed] [Related articles]
2.	Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694. Laffly E, Danjou L, Condemine F, Vidal D, Drouet E, Lefranc MP, Bottex C, Thullier P Antimicrob Agents Chemother 2005 Aug, 49:3414-20 [PubMed Central] [PubMed] [Related articles]
3.	An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin. Lim NK, Kim JH, Oh MS, Lee S, Kim SY, Kim KS, Kang HJ, Hong HJ, Inn KS Infect Immun 2005 Oct, 73:6547-51 [PubMed Central] [PubMed] [Related articles]
4.	Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax. Peterson JW, Comer JE, Noffsinger DM, Wenglikowski A, Walberg KG, Chatuev BM, Chopra AK, Stanberry LR, Kang AS, Scholz WW, Sircar J Infect Immun 2006 Feb, 74:1016-24 [PubMed Central] [PubMed] [Related articles]
5.	Neutralizing antibodies and persistence of immunity following anthrax vaccination. Hanson JF, Taft SC, Weiss AA Clin Vaccine Immunol 2006 Feb, 13:208-13 [PubMed Central] [PubMed] [Related articles]
6.	Genetic medicine strategies to protect against bioterrorism. Boyer JL, Crystal RG Trans Am Clin Climatol Assoc 2006, 117:297-310; discussion 310-1 [PubMed Central] [PubMed] [Related articles]
7.	Rabies virus glycoprotein as a carrier for anthrax protective antigen. Smith ME, Koser M, Xiao S, Siler C, McGettigan JP, Calkins C, Pomerantz RJ, Dietzschold B, Schnell MJ Virology 2006 Sep 30, 353:344-56 [PubMed Central] [PubMed] [Related articles]
8.	High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Pelat T, Hust M, Laffly E, Condemine F, Bottex C, Vidal D, Lefranc MP, Dübel S, Thullier P Antimicrob Agents Chemother 2007 Aug, 51:2758-64 [PubMed Central] [PubMed] [Related articles]
9.	Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model. Peterson JW, Comer JE, Baze WB, Noffsinger DM, Wenglikowski A, Walberg KG, Hardcastle J, Pawlik J, Bush K, Taormina J, Moen S, Thomas J, Chatuev BM, Sower L, Chopra AK, Stanberry LR, Sawada R, Scholz WW, Sircar J Infect Immun 2007 Jul, 75:3414-24 [PubMed Central] [PubMed] [Related articles]
10.	Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax. Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW Infect Immun 2007 Nov, 75:5425-33 [PubMed Central] [PubMed] [Related articles]
11.	Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy. Sherer K, Li Y, Cui X, Eichacker PQ Am J Respir Crit Care Med 2007 Feb 1, 175:211-21 [PubMed Central] [PubMed] [Related articles]
12.	Selection and characterization of human antibodies neutralizing Bacillus anthracis toxin. Zhou B, Carney C, Janda KD Bioorg Med Chem 2008 Feb 15, 16:1903-13 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 2 articles in BioMed Central

printer friendly

to [Help]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us